DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
CAM2038 is an investigational drug.
There have been 9 clinical trials for CAM2038. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2020.
The most common disease conditions in clinical trials are Disease, Substance Withdrawal Syndrome, and Opioid-Related Disorders. The leading clinical trial sponsors are Braeburn Pharmaceuticals, Theresa Winhusen, PhD, and The EMMES Corporation.
There are two US patents protecting this investigational drug and twenty-six international patents.
Recent Clinical Trials for CAM2038
|Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study||National Institute on Drug Abuse (NIDA)||Phase 3|
|Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study||The EMMES Corporation||Phase 3|
|Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study||Theresa Winhusen, PhD||Phase 3|
Top disease conditions for CAM2038
Top clinical trial sponsors for CAM2038
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|CAM2038||Start Trial||Tactile sensing device for lumbar punctures||TEXAS MEDICAL CENTER (Houston, TX)||Start Trial|
|CAM2038||Start Trial||Methods and devices to reduce damaging effects of concussive or blast forces on a subject||TBI INNOVATIONS, LLC (Richmond, IN) THORNHILL RESEARCH, INC. (Toronto, Ontario, CA)||Start Trial|
|CAM2038||Start Trial||Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof||Start Trial|
|CAM2038||Start Trial||Therapeutic compounds and methods of use thereof||GENENTECH, INC. (South San Francisco, CA) XENON PHARMACEUTICALS INC. (Burnaby, BC, CA)||Start Trial|
|CAM2038||Start Trial||Heterocyclic flavone derivatives, compositions, and methods related thereto||Emory University (Atlanta, GA)||Start Trial|
|CAM2038||Start Trial||Transdermal dosage form||Barr Laboratories, Inc. (Pomona, NY)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|CAM2038||European Patent Office||3451925||2036-05-03||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|